Nevan Krogan

Co-Founder & CEO at Rezo Therapeutics

Nevan Krogan, Ph.D., is a Co-Founder and the Chief Executive Officer of Rezo. Nevan is a Professor at the University of California, San Francisco (UCSF), Director of Quantitative Biosciences Institute (QBI) and a Senior Investigator at Gladstone Institutes. Nevan has authored over 350 papers in the fields of genetics and molecular and systems biology and has given over 400 lectures and seminars around the world. He is a Searle Scholar, a Keck Distinguished Scholar, a recipient of the Roddenberry Prize for Biomedical Research as well as the Louis Pasteur Medal, and was recently elected to the European Molecular Biology Organization (EMBO). In recognition of his collaborative work bringing scientists across the globe to work together on SARS-CoV-2, and most notably French scientists, Nevan was awarded the French Legion of Honor in 2022. Nevan received a Ph.D. in Medical Genetics from University of Toronto and a M.Sc. in Biology and B.Sc. in Biochemistry from University of Regina in Saskatchewan, Canada.


Org chart

Sign up to view 11 direct reports

Get started